INS and type 2 diabetes mellitus: We further show that, in the homozygous state, this variation leads to a substantial loss of GSIS response, while in the heterozygous state, this variant results in a significantly reduced insulin secretory response that explains the very early onset of diabetes in the one homozygous individual and increased type 2 diabetes risk in the adult heterozygous carriers.